Coherus BioSciences — The biopharma stock soared 34% after the U.S. Food and Drug Administration approved Udenyca Onbody, an on-body injection system that patients take in conjunction with chemotherapy to prevent infection. The injection targets febrile neutropenia, the onset of fever in a patient with abnormally low white blood cells and a common side effect in chemotherapy patients. The company expects Udenyca Onbody to be commercially available beginning in the first quarter of next year.
Amazon — The tech titan revealed that starting Jan. 29, advertisements will be incorporated into its Prime Video service. Customers also have the option to pay $2.99 to opt out. Amazon shares remained little changed in active premarket trading.
Tesla — Shares of the electric vehicle maker ticked fractionally higher after the company announced a revamp of its Model Y vehicle, Bloomberg News reported, citing familiar sources. Tesla expects to refresh the model from its Shanghai plant beginning in the middle of next year.
